These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13929385)

  • 21. Gait control in spinal palsy.
    Dan B; Bouillot E; Mewasingh LD; Devalck C; Bengoetxea A; Christophe C; Chéron G
    Brain Dev; 2004 Oct; 26(7):463-8. PubMed ID: 15351083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ON THE BORDERLINE OF NEUROLOGY AND GERONTOLOGY: A CASE OF PSEUDO-MULTIPLE SCLEROSIS CAUSED BY MYELOPATHY SECONDARY TO CERVICAL SPONDYLOSIS].
    TASSINARI G
    G Gerontol; 1963 Nov; 11():1183-7. PubMed ID: 14124933
    [No Abstract]   [Full Text] [Related]  

  • 23. [STUDIES ON THE SPINAL REFLEX USING ELECTROMYOGRAPHY. ON REFLEX WAVES OF THE INTRINSIC MUSCLES OF THE HAND].
    KAWATA T
    Nihon Seikeigeka Gakkai Zasshi; 1963 Aug; 37():365-73. PubMed ID: 14084139
    [No Abstract]   [Full Text] [Related]  

  • 24. Reconstructive surgery of the hand in cerebral palsy and spastic paralysis resulting from injury to the spinal cord.
    GOLDNER JL
    J Bone Joint Surg Am; 1955 Dec; 37-A(6):1141-53; discussion, 1153-4; passim. PubMed ID: 13271461
    [No Abstract]   [Full Text] [Related]  

  • 25. Reciprocal excitation of antagonistic muscles as a differentiating feature in spasticity.
    Myklebust BM; Gottlieb GL; Penn RD; Agarwal GC
    Ann Neurol; 1982 Oct; 12(4):367-74. PubMed ID: 7149662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of motor disorders in the spastic form of infantile cerebral palsy with galanthamine and ganglerone combined with functional biocontrol technics].
    Shaĭtor VM; Bogdanova OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):37-9. PubMed ID: 3195280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal inhibition and motor function in adults with spastic cerebral palsy.
    Condliffe EG; Jeffery DT; Emery DJ; Gorassini MA
    J Physiol; 2016 May; 594(10):2691-705. PubMed ID: 26842905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations with high Mydocalm doses in the treatment of internal diseases.
    Udvardi G
    Ther Hung; 1987; 35(1):23-7. PubMed ID: 3438860
    [No Abstract]   [Full Text] [Related]  

  • 29. Dynamic spasticity of plantar flexor muscles in cerebral palsy gait.
    van der Krogt MM; Doorenbosch CA; Becher JG; Harlaar J
    J Rehabil Med; 2010 Jul; 42(7):656-63. PubMed ID: 20603696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal treatment for spasticity.
    Miles J
    Stereotact Funct Neurosurg; 2001; 76(3-4):246-8. PubMed ID: 12378104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New therapies for spastic movement disorders].
    Benecke R; Patejdl R
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract]   [Full Text] [Related]  

  • 32. Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin.
    Abrányi I
    Ther Hung; 1988; 36(2):56-61. PubMed ID: 3201387
    [No Abstract]   [Full Text] [Related]  

  • 33. New spasticity from cervical spine pathology in a patient with athetoid cerebral palsy.
    Allen LM; Nigogosyan MA
    Neurology; 2008 Apr; 70(18):1647. PubMed ID: 18443319
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.
    Paolucci S; Martinuzzi A; Scivoletto G; Smania N; Solaro C; Aprile I; Armando M; Bergamaschi R; Berra E; Berto G; Carraro E; Cella M; Gandolfi M; Masciullo M; Molinari M; Pagliano E; Pecchioli C; Roncari L; Torre M; Trabucco E; Vallies G; Zerbinati P; Tamburin S;
    Eur J Phys Rehabil Med; 2016 Dec; 52(6):827-840. PubMed ID: 27579581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of the H reflex in spastic subjects treated with a GABA derivative (Ciba 34647-BA)].
    Fra L; Bergamini L; Brignolio F; Delsedime M
    Riv Neurol; 1971; 41(3):152-60. PubMed ID: 5126432
    [No Abstract]   [Full Text] [Related]  

  • 36. [ROLE OF PHARMACOLOGICAL PREPARATIONS IN THE TREATMENT OF MOTOR DISORDERS IN CHILDREN WITH CEREBRAL PALSY].
    BUKSOWICZ C
    Neurol Neurochir Psychiatr Pol; 1964; 14():35-41. PubMed ID: 14196364
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].
    Stamenova P; Koytchev R; Kuhn K; Hanasen C; Horvath F; Ramm S; Pongratz D
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):34-42. PubMed ID: 16457132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke.
    Stamenova P; Koytchev R; Kuhn K; Hansen C; Horvath F; Ramm S; Pongratz D
    Eur J Neurol; 2005 Jun; 12(6):453-61. PubMed ID: 15885050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathomorphological changes of basic argyrophyle substance in the muscles of patients with cerebral spastic paralysis].
    MEZHENINA EP
    Ortop Travmatol Protez; 1961 Aug; 22():54-7. PubMed ID: 13770087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.